Cited 3 times in

Radiosensitizers in hepatocellular carcinoma

Title
Radiosensitizers in hepatocellular carcinoma
Authors
Ik Jae Lee;Jinsil Seong
Issue Date
2011
Journal Title
Seminars in Radiation Oncology
ISSN
1053-4296
Citation
Seminars in Radiation Oncology, Vol.21(4) : 303~311, 2011
Abstract
Most hepatocellular carcinoma (HCC) patients present with locally advanced disease with a risk of development of intrahepatic or extrahepatic metastases. Conformal radiotherapy (RT) can be delivered to focal HCCs with sustained local control in selected HCC patients. However, it is frequently not possible to deliver tumoricidal doses to locally advanced HCC due to the risk of radiation-induced liver toxicity or the risk of toxicity to adjacent luminal gastrointestinal organs. Combining RT with radiosensitizers is an attractive strategy to increase the therapeutic ratio for these patients. Clinical experience in combining RT and radiosensitizers in HCC is limited. Hepatic arterial chemoembolization (or transcatheter arterial chemoembolization, TACE) has been used in combination with RT for the treatment of HCC, as have halogenated pyrimidines. More recently, there is a growing experience of RT delivered with molecular targeted agents in HCC. In this review, the rationale for potential radiation sensitization and the clinical experience in HCC for different classes of radiation sensitizers are discussed.
URI
http://www.sciencedirect.com/science/article/pii/S1053429611000506

http://ir.ymlib.yonsei.ac.kr/handle/22282913/94077
DOI
10.1016/j.semradonc.2011.05.008
Appears in Collections:
1. 연구논문 > 1. College of Medicine > Dept. of Radiation Oncology
Yonsei Authors
사서에게 알리기
  feedback
Files in This Item:
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse